Outcome from Schizophrenia throughout the Twentieth Century
Is Outcome of Schizophrenia really better in the developing world?
Adolescent Cannabis Use and Later Psychosis
What we know and what we don't know about how antipsychotics work
Australian Mental Health Service reforms : the good, the bad and the way forward
The Neuroscience of Schizophrenia
Understanding cognition in schizophrenia : control, disorganization and the frontal cortex
Early Intervention in Psychosis : A Critique
Early Intervention In Psychosis
How critical is early intervention for psychoses in developing countries?
How critical is early intervention for psychoses in developing countries?
SCAP : A prospective study of outcomes in patients with schizophrenia
SCAP : A prospective study of outcomes in patients with schizophrenia
Results from a multisite effectiveness evaluation of Early Psychosis treatment : Applying hierarchical linear modeling
The DEPTH project : A multisite RCT for youths at risk for psychosis
Identifying Individuals At Ultra-High Risk Of Developing Psychosis : O:05
The Case for Dual Antipsychotic Use in Treatment Resistant Schizophrenia : O:06
Social Rituals and Early Detection of Mental Illness : O:07
Reducing symptoms of PTSD amongst carers of people with psychosis : a pilot study examining the impact of writing about caregiving experiences
Animal Models for Schizophrenia, Why do we Bother? : O:09
Modeling cognitive deficits in schizophrenia using rodents : O:10
Prepulse Inhibition of the Startle Reflex in Patients Treated With Atypical Neuroleptics : O:11
The somatosensory system and schizophrenia : O:12
Maternal deprivation and corticosterone administration in rats as a neurodevelopmental model of schizophrenia : effects on behaviour and dopamine receptor density
Developmental Vitamin D Depletion alters adult rat behaviour and response to psychomimetic drugs : a relevant model for schizophrenia
Brain development disruption from PCP causes behavioural deficits in the forced swim test in later life : O:15
Genetic animal models for neuregulin 1 - valuable tools for schizophrenia research? : O:16
Evidence from MMN of temporal processing deficits in schizophrenia : O:17
Temporal processing in schizophrenia-evidence for impairment across a range of time scales : O:18
Insensitivity to temporal context in schizophrenia : O:19
Mismatch negativity (MMN), executive function and symptom severity in 1st episode and chronic schizophrenia : O:20
Spatiotemporal activation of MMN generators in schizophrenia : O:21
Between channel gap detection as a measure of left hemisphere advantage for temporal processing in the auditory system : O:22
Social cognition in schizophrenia : Paying attention to context
Theory-of-mind impairment in schizophrenia : a domain-general difficulty with perspective-taking
Automated and controlled processing of fear facial expression display dysfunctions in the amygdala pathways in schizophrenia : a functional connectivity approach
Are visuo-cognitive disturbances in first-degree relatives of schizophrenia patients evidence for a vulnerability marker? : O:26
Emotion recognition training normalizes visual scan paths to faces in schizophrenia : O:27
Remediation of facial affect decoding and visual scanpath deficits in schizophrenia : O:28
Hits from the bong : An update on a functional imaging study of cannabis use and schizophrenia
Cannabis and cognition : Relevance to psychotic disorders
Treating cannabis abuse in people with psychosis : O:31
Cannabis, health, and the law : O:32
Is the risk of intellectual disability, rare syndromes or epilepsy elevated in the children of women with a psychotic illness? Results from a Western Australian population-based cohort study : O:33
Lifetime prevalence of psychosis by age 21 in an Australian birth cohort : O:34
Cognition and Brain in Children with 22q11.2 Deletion Syndrome : O:35
Brain and Behaviour in Children with 22q11.2 Deletion Syndrome : A Volumetric and Voxel-Based Morphometry MRI Study
Cognitive functions and metabolite changes in frontal lobe and in thalamus of first onset schizophrenic patients using proton MRS : O:37
Volumetric white matter abnormalities in first-episode schizophrenia : a longitudinal MRI study
Hippocampal Volume and MR Spectroscopy in Early Psychosis : A Cross-Sectional Comparison of Neuroleptic-Naive and Early-Treated Patients
Longitudinal changes in regional grey matter volume and corresponding EEG power in first-episode psychosis : O:40
Challenging dorsal anterior cingulate hypofunction in schizophrenia : An fMRI study of cognitive conflict
Auditory Hallucinations in Psychosis : altered cortical connectivity and “release” in neural substrates of episodic verbal memory and central auditory processing
Trancranial Magnetic Stimulation - A Novel Treatment for Auditory Hallucinations in Schizophrenia? : O:43
Changed kainate receptors in the Brodmann's area 9 from subjects with schizophenia : O:44
M1/M4 receptor expression in the hippocampus from subjects with schizophrenia : O:45
Proteome analysis of the corpus callosum of schizophrenia : O:46
Atypical antipsychotics associated with insulin resistance in New Zealand Maori : O:47
Antipsychotic drug effects on GABAA receptors : O:48
Neurochemical changes in frontal and temporal lobe of schizophrenic patients on conventional antipsychotic and clozapine treatment : O:49
Cognitive Deficits, Length of Illness & Symptom Severity in Schizophrenia : O:50
Preserved versus compromised intellectual functioning in first-episode psychosis : patterns of cognitive functioning and stability over time
Personality traits in genetically distinct groups of schizophrenia patients and their relatives : O:52
Source Monitoring and Auditory Hallucinations in Clinical and Non-clinical Samples : O:53
Normal and Anomalous Classification of Category Exemplars in Schizophrenia : O:54
Cognitive mechanisms of depression in schizophrenia : O:55
The SRM as an Explanatory Model in Schizophrenia : O:56
Analysis of linkage disequilibrium with schizophrenia in three candidate genes : GRM-3, AKT-1 and NRG-1
Evaluation of linkage disequilibrium in the TNF alpha gene region on chromosome 6p in families with schizophrenia : O:58
The presence of alternatively spliced variants and the relative expression of dysbindin in lymphoblast cell lines of schizophrenic patients : O:59
Lack of association of DRD2 gene TaqI polymorphism with schizophrenia in an Iranian population : O:60
Dysfunction of genes regulating membrane exocytosis in schizophrenia : O:61
Investigation of associations between Single Nucleotide Polymorphisms (SNP) of the Muscarinic1 Receptor (M1R) gene and cognitive deficits in schizophrenia : O:62
Violent Behaviour Associated with a Novel ApoB Gene Mutation (apoB-29.4), which causes Hypocholesterolemia : O:63
Molecular mechanisms of Lithium Chloride : What can mice teach us about Bipolar Disorder?
Jumping to delusions in early psychosis : O:65
Referential delusions of communication and self-monitoring deficits in psychosis : O:66
Psychotic-Like Experiences in Non-Psychotic Help-Seekers : Associations with distress, depression and disability
Dissociative Experiences And Transition To Psychosis : O:68
Course and outcome of psychosis in the East Kimberley : O:69
You can't have a baby - you have schizophrenia : O:70
Creative Expression Centre For Arts Therapy And Reflections Art Studio : Two Unique Art Therapy Mental Health Recovery Programs
Pathways of risk from conception to disease for the high risk offspring of women with psychoses. Issues in the design of a population health database : P:01
Pathways of risk from conception to disease for the high risk offspring of women with psychoses. Protocol for the collection of clinical data : P:02
Pathways of risk from conception to disease for the high risk offspring of women with psychoses. Modelling the incidence and determinants of psychiatric morbidity : P:03
A systematic review of mortality in individuals with schizophrenia : preliminary results
Disease burden of bipolar and schizoaffective disorder in an Australian cohort : P:05
Burden of care caregivers of schizophrenia : A study from northern India
A Single Case Examination of a Distinct Subtype of Schizophrenia : P:07
Analysis of the background EEG as a proxy for electrophysiological endophenotypes in the WA Family Study of Schizophrenia : Description of method and preliminary data
fMRI evidence of altered auditory temporal processing in schizophrenia : P:09
Contribution to span performance in schizophrenia : the role of rehearsal speed and lexical access
A Proteomic Analysis of Brodmann's Area 46 (BA46) in Schizophrenia : P:11
Intentional inhibition deficits in individuals predisposed to hallucinations : P:12
Emotional prosodic processing & source monitoring in auditory hallucinations : P:13
Clinical correlates of olfactory hallucinations in schizophrenia : P:14
Identification of Proteins Differentially Expressed in the Schizophrenic Hippocampus : P:15
Prepulse inhibition is not disrupted in adult rats treated as neonates with capsaicin : P:16
Relationships between the symptomatology and neuropsychology of schizophrenia : three, five, or a greater number of valid syndromes?
Functional Brain Imaging Of Auditory Prepulse Inhibition : P:18
The use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia -A Pilot Study : P:19
Pharmacotherapy of Catatonia in Schizophrenia : P:20
Treatment with Antipsychotics and Disability in Schizophrenia : Comparison with Never-Treated Patients Living in Community
WAPDC Antipsychotic Guidelines 2006 : P:22
Victorian consensus guidelines for monitoring the safe use of clozapine : P:23
Change of Cognitive Functions on Switching of Risperidone for Chronic Schizophrenic Patients : P:24
Risperidone alone versus risperidone and citalopram in patients with neuroleptic-naïve, recent-onset schizophrenia : a randomized double-blind study